Bergstein Ivan
Chief Executive Officer at STEMLINE THERAPEUTICS INC
- Sold, on record
- $5.8M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Apr 15, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- STEMLINE THERAPEUTICS INCChief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedMar 7 2019
Sold 6,800 shares at $11.41 ($78k)
Bergstein Ivan, Chief Executive Officer
Sold 0.2% of holdings ($31.1M position)2.7M shares left0.3x usual sizeFiling
- 2 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedMar 12 +5 days
Sold 57,224 shares at $11.11 ($636k)
Bergstein Ivan, Chief Executive Officer
Sold 2.1% of holdings ($30.2M position)2.7M shares left2.5x usual sizeFiling
- 3 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedJun 26 +106 days
Sold 56,316 shares at $15.08 ($849k)
Bergstein Ivan, Chief Executive Officer
Sold 2.1% of holdings ($40.1M position)2.6M shares left2.4x usual sizeFiling
- 4 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedAug 14 +49 days
Sold 35,010 shares at $14.73 ($516k)
Bergstein Ivan, Chief Executive Officer
Sold 1.3% of holdings ($38.4M position)2.6M shares left1.4x usual sizeFiling
- 5 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedDec 27 +135 days
Sold 56,028 shares at $10.84 ($607k)
Bergstein Ivan, Chief Executive Officer
Sold 2.2% of holdings ($27.9M position)2.5M shares left1.9x usual sizeFiling
- 6 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedFeb 25 +60 days
Sold 24,642 shares at $6.42 ($158k)
Bergstein Ivan, Chief Executive Officer
Sold 0.8% of holdings ($18.9M position)2.9M shares left0.7x usual sizeFiling
- 7 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedMar 10 +14 days
Sold 57,451 shares at $4.98 ($286k)
Bergstein Ivan, Chief Executive Officer
Sold 2% of holdings ($14.5M position)2.9M shares left1.6x usual sizeFiling
- 8 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedApr 15 +36 days
Sold 53,618 shares at $4.88 ($262k)
Bergstein Ivan, Chief Executive Officer
Sold 1.9% of holdings ($13.9M position)2.8M shares left1.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (22)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2020 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 53,618 | $262k | 1.9% | Plan not stated | SEC |
| Mar 10, 2020 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 57,451 | $286k | 2.0% | Plan not stated | SEC |
| Feb 25, 2020 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 24,642 | $158k | 0.8% | Plan not stated | SEC |
| Dec 27, 2019 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 56,028 | $607k | 2.2% | Plan not stated | SEC |
| Aug 14, 2019 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 35,010 | $516k | 1.3% | Plan not stated | SEC |
| Jun 26, 2019 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 56,316 | $849k | 2.1% | Plan not stated | SEC |
| Mar 12, 2019 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 57,224 | $636k | 2.1% | Plan not stated | SEC |
| Mar 7, 2019 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 6,800 | $78k | 0.2% | Plan not stated | SEC |
| Feb 25, 2019 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 22,905 | $276k | 0.8% | Plan not stated | SEC |
| Feb 14, 2019 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 34,132 | $375k | 1.2% | Unusual | SEC |
| Mar 12, 2018 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 37,857 | $656k | 1.7% | Unusual | SEC |
| Mar 7, 2018 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 6,797 | $113k | 0.3% | Plan not stated | SEC |
| Feb 27, 2018 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 24,183 | $421k | 1.2% | Unusual | SEC |
| Feb 15, 2018 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 3,820 | $60k | 0.2% | Plan not stated | SEC |
| Mar 7, 2017 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 5,401 | $44k | 0.3% | Plan not stated | SEC |
| Feb 28, 2017 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 17,980 | $126k | 1.0% | Unusual | SEC |
| Feb 16, 2017 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 3,652 | $23k | 0.2% | Plan not stated | SEC |
| Mar 8, 2016 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 5,537 | $30k | 0.3% | Plan not stated | SEC |
| Feb 17, 2016 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 3,244 | $14k | 0.2% | Plan not stated | SEC |
| Nov 30, 2015 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 12,235 | $100k | 0.6% | Plan not stated | SEC |
| Feb 18, 2015 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 3,180 | $45k | 0.2% | Plan not stated | SEC |
| Nov 26, 2014 | STEMLINE THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 11,974 | $172k | 0.6% | Plan not stated | SEC |